OKYO Pharma Limited
OKYO
$2.43
$0.062.53%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -4.71M | -7.70M | -10.69M | -13.76M | -16.83M |
| Total Depreciation and Amortization | 2.60K | 2.80K | 3.00K | 3.40K | 3.80K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.27M | 2.69M | 4.10M | 4.38M | 4.66M |
| Change in Net Operating Assets | 1.63M | 2.63M | 3.64M | 3.16M | 2.67M |
| Cash from Operations | -1.81M | -2.38M | -2.94M | -6.21M | -9.49M |
| Capital Expenditure | -1.20K | -600.00 | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -1.20K | -600.00 | -- | -- | -- |
| Total Debt Issued | 950.00K | 475.90K | 1.80K | 900.00 | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 1.71M | 2.23M | 2.76M | 4.48M | 6.21M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 2.66M | 2.71M | 2.76M | 4.48M | 6.21M |
| Foreign Exchange rate Adjustments | -109.60K | -280.60K | -451.60K | -194.00K | 63.60K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 734.20K | 52.00K | -630.20K | -1.92M | -3.22M |